Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
View Patent ↗Provided herein are polypeptides designated CVSP14 polypeptides that exhibit protease activity as a single chain or as an activated two chain form. Methods using the polypeptides to identify compounds that modulate the protease activity thereof are provided. The polypeptides also serve as tumor markers.
1. A substantially purified two chain protease comprising a CVSP14 protease domain having the sequence of amino acid residues set forth in SEQ ID No. 6.
2. The substantially purified protease of claim 1 that is a human protease.
3. The activated two chain protease of claim 1 , wherein a free cysteine in the protease domain is replaced with another amino acid.
4. The protease of claim 3 , wherein the cysteine is replaced by a conservative amino acid substitution.
5. The protease of claim 4 , wherein the replacing amino acid is a serine.
6. A substantially purified protease that consists of the sequence of amino acid residues set forth in SEQ ID No. 6.
7. A substantially purified single chain or activated two chain CVSP14 protease that comprises a sequence of amino acids selected from the group consisting of:
(a) the sequence of amino acids encoded by the sequence of nucleotides set forth in SEQ ID No. 12; and
(b) the sequence of amino acids set forth in SEQ ID No. 13.
8. The substantially purified CVSP14 protease of claim 7 , that is a single chain protease consisting of the sequence of amino acids set forth in SEQ ID No. 12.
9. The substantially purified CVSP14 protease of claim 7 , that is an activated two-chain protease consisting of the sequence of amino acids set forth in SEQ ID No. 12.
10. The substantially purified protease of claim 7 that is a human protease.
11. The substantially prurified protease of claim 7 , wherein a free cysteine in the protease domain is replaced with another amino acid.
12. The polypeptide of claim 11 , wherein the replacing amino acid is a serine.
13. A conjugate, comprising the protease of claim 1 , and a targeting agent linked to the protease directly or via a linker.
14. The conjugate of claim 13 , wherein the targeting agent permits
i) affinity isolation or purification of the conjugate;
ii) attachment of the conjugate to a surface;
iii) detection of the conjugate; or
iv) targeted delivery of the conjugate to a selected tissue or cell.
15. A conjugate, comprising the protease of claim 7 , and a targeting agent linked to the protease directly or via a linker.
16. The conjugate of claim 15 , wherein the targeting agent permits
i) affinity isolation or purification of the conjugate;
ii) attachment of the conjugate to a surface;
iii) detection of the conjugate; or
iv) targeted delivery of the conjugate to a selected tissue or cell.
17. A conjugate, comprising the protease of claim 9 , and a targeting agent linked to the protease directly or via a linker.
18. The conjugate of claim 17 , wherein the targeting agent permits
i) affinity isolation or purification of the conjugate;
ii) attachment of the conjugate to a surface;
iii) detection of the conjugate; or
iv) targeted delivery of the conjugate to a selected tissue or cell.
19. A solid support, comprising two or more proteases of claim 1 or claim 7 linked thereto either directly or via a linker.
20. The support of claim 19 , wherein the proteases comprise an array.
21. The support of claim 20 , wherein the array further comprises a plurality of different protease domains.
22. A method for identifying compounds that inhibit the protease activity of the activated two-chain protease of claim 1 , comprising:
contacting the protease of claim 1 with a substrate that is proteolytically cleaved by the protease, and, either simultaneously, before, or after, adding a test compound or plurality thereof;
measuring the amount of substrate cleaved in the presence of the test compound; and,
selecting test compounds that decrease the amount of substrate cleaved compared to a control,
thereby identifying compounds that inhibit the activity of the protease.
23. The method of claim 22 , wherein the test compounds are small molecules, peptides, peptidomimetics, natural products, antibodies or fragments thereof that inhibit the activity of the protease.
24. The method of claim 22 , wherein the control measures the amount of substrate cleaved by the protease in the absence of the test compound.
25. The method of claim 22 m wherein a plurality of the test compounds are screened simultaneously.
26. The method of claim 25 , wherein a plurality of the proteases are linked to a solid support, either directly or via a linker.
27. The method of claim 26 , wherein the proteases comprise an array.
28. The method of claim 22 , wherein the protease consists of the sequence of amino acid residues set forth in SEQ ID No. 6.
29. A method for identifying compounds that inhibit the protease activity of the protease of claim 4 , comprising:
contacting the protease of claim 4 with a substrate that is proteolytically cleaved by the protease and, either simultaneously, before or after, adding a test compound or plurality thereof;
measuring the amount of substrate cleaved in the presence of the test compound; and
selecting compounds that change the amount of substrate cleaved compared to a control,
thereby identifying compounds that inhibit the activity of the protease.
30. A method for identifying compounds that inhibit the protease activity of the protease of claim 9 comprising:
contacting the protease of claim 9 with a substrate that is proteolytically cleaved by the protease, and, either simultaneously, before, or after, adding a test compound or plurality thereof;
measuring the amount of substrate cleaved in the presence of the test compound; and,
selecting test compounds that decrease the amount of substrate cleaved compared to a control,
thereby identifying compounds that inhibit the activity of the protease.